Industry & Company Headlines

• New Study Touts the Impact of NIH Spending on State Economies
  In fiscal year 2007, NIH awarded about $22.8 billion in grants and contracts to universities and other research institutions in the 50 states The value of NIH state awards ranged from $3.5 billion (California) to $7 million (Wyoming). A recent study by Families USA quantified the economic impact of such spending and found that, among other things, each dollar of NIH funding generated more than twice as much in state economic output. That is, an overall investment of $22.8 billion from NIH generated a total of $50.5 billion in new state business activity in the form of increased output of goods and services. Click here to access report
• Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
  "We look forward to a close partnership with the DTRA during the performance of this program;" said SoCalBio member Ronald Aimes, Ph.D., associate director of research & development at Peregrine and principal investigator on the contract. "This is an exciting opportunity for Peregrine to contribute to the country's defenses while also achieving important synergies with our development programs for bavituximab and our earlier stage anti-PS technologies." read press release

• Advanced Medical optics (Santa Ana):
  • AMO Enters into Cross-Licensing Patent Agreement with Alcon
• Bausch & Lomb ((Aliso Viejo):
  • Crystalens HD Receives FDA Approval
• HairDx (Irvine):
  • HairDX Selling Genetic Baldness Test To Physicians Only
• ImmunoCellular Therapeutics (Woodland Hills):
  • ImmunoCellular Therapeutics Elects Dr. Navdeep Jaikaria to Board of Directors
• Interventional Spine (Irvine):
  • FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
• Molecular Express (Rancho Dominguez):

  • Molecular Express awarded SBIR Phase II funding for its genital herpes vaccine

• Sanguine Corp. (Pasadena):
  • Sanguine Corporation Completes the Formation of Life Sciences Subsidiary
• SenoRx (Aliso Viejo):
  • SenoRx Receives Additional 510(k) Clearance for Its Contura MLB
• Synthetic Blood International (Costa Mesa):
  • Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
• Watson Pharmaceuticals (Corona):
  • Watson Pharma launches generic nausea drug

Utilize SoCalBio Resources

Open Positions

This biotech company develops unique products that diagnose, treat, and prevent bacterial and fungal infections. C3 Jian is now recruiting a COO with proven business development track record .. click here to see job description.

RSVP Now

September 19, 2008

Recommended Events

The Meeting Place for the Bioprocessing Industry to Learn New Approaches to Biopharmaceutical Manufacturing

September 23 - 26
Disneyland Hotel, Anaheim
http://www.ibclifesciences.com/B8171/overview.xml

Welcome New Members

• Commercial Capital Resources (Sherman Oaks)
  Offering B2B services to owners and corporate executives in areas such as commercial finance, leasing, lending and factoring, R&D tax credit, profit recovery and expense reduction techniques. Company will be represented in SoCalBio by Peter Athanas, Business Consultant, Expense Reduction Adviser, Broker (818 621 9886 -- peter@commcapresources.com)

Join SoCalBio

Do You Know?

SoCalBio membership provides access to Business Wire as your primary outlet for news distribution at a discounted price through the SoCalBio group purchasing program. To get more info, contact Mark Essa, VP, Business Wire/LA at 310-820-9473 -- mark.essa@businesswire.com or Christie Brockhage, Regional Manager, Business Wire/Newport Beach at 949-757-1021 -- christie.brockhage@businesswire.com

Access Past Weekly Updates